new tirzepatide drug FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly 新型減肥皮下注射針劑tirzepatide diarrhea Program:Low-Dose Plan (up to 5mg/wk)

new tirzepatide drug FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly 新型減肥皮下注射針劑tirzepatide diarrhea Program:Low-Dose Plan (up to 5mg/wk)

新型減肥皮下注射針劑tirzepatide

Interestingly, the previously observed positive contrast effect was spared in S2, with a weaker residual effect specifically on the consumption of the more palatable pellet type

diarrhea

Program:Low-Dose Plan (up to 5mg/wk)

Fever above 101 degrees Fahrenheit (38.3 Celsius) alongside diarrhea suggests an infection rather than a medication side effect